May 06, 2026

Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis

Caris MI Clarity leverages AI to transform how recurrence risk is understood and applied in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer IRVING, Texas, May 5, 2026 /PRNewswire/ -- Caris Life Sciences®...

recent articles

WEBINAR – THURSDAY, OCTOBER 24TH 11 am CEST – SAVE YOUR SEAT 10 am PDT | 1 pm EDT – SAVE YOUR SEAT Join Visiopharm Thursday, 24th of October for a peek at the new image analysis algorithm that will simplify your workflow and...

U.S. Patent No. 10,346,980 addresses techniques critical to the advancement of digital pathology PHILADELPHIA (PRWEB) SEPTEMBER 24, 2019 -- Proscia, a leading provider of digital pathology software, has been granted U.S. Patent No. 10,346,980...

23 October, 2019  8:00 PDT | 11:00 EDT | 16:00 BST | 23:00 CST Presented by Anne Hellebust, PhD | Life Sciences Product Manager, Indica Labs, Inc. Vlado Ovtcharov | Senior Algorithm Engineer, Indica Labs,...

Mumbai/Misgav/North Carolina — Life sciences Artificial Intelligence products and services company, AIRA Matrix (“AIRA Matrix”), and microscope-based digital pathology platform Augmentiqs (“Augmentiqs”), announced the world’s first...

by: Amy Baxter Stanford researchers have developed an AI tool that can help diagnose damaging brain aneurysms that can have potentially fatal effects. The development of the tool was detailed in a...

OR

platinum partners

gold partners

Silver Partners

Media Partners